In several studies on potential drugs improving insulin sensitivity in T2DM, vaspin, like other adipokines such as omentin, visfatin, or adiponectin, is considered a biomarker of diabetes and a potential indicator of drug efficiency [104,105]. This evidence concerns the gene INS and diabetes mellitus.